quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:22:58·43d
SECFiling
ProQR Therapeutics N.V. logo

SEC Form 20-F filed by ProQR Therapeutics N.V.

PRQR· ProQR Therapeutics N.V.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • PRQR
    ProQR Therapeutics N.V.
    Health Care

Recent analyst ratings

  • Mar 12UpdateOppenheimer$9.00
  • Apr 29UpdateEvercore ISI$5.00
  • Apr 29UpdateCantor Fitzgerald$8.00
  • Mar 10UpdateCitigroup$4.00
  • Jan 10UpdateOppenheimer$15.00
  • Oct 29UpdateRaymond James$14.00

Related

  • SEC15d
    SEC Form 6-K filed by ProQR Therapeutics N.V.
  • PR15d
    ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
  • SEC16d
    SEC Form 6-K filed by ProQR Therapeutics N.V.
  • PR16d
    ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
  • SEC30d
    SEC Form 6-K filed by ProQR Therapeutics N.V.
  • PR30d
    ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
  • INSIDER36d
    SEC Form 3 filed by new insider Valerio Domenico
  • INSIDER36d
    SEC Form 3 filed by new insider Platenburg Gerardus Johannes
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022